The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMurray International Regulatory News (MYI)

Share Price Information for Murray International (MYI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 254.50
Bid: 255.50
Ask: 256.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.196%)
Open: 256.50
High: 257.00
Low: 254.50
Prev. Close: 254.50
MYI Live PriceLast checked at -
Murray International is an Investment Trust

To achieve an above average dividend yield, with long term growth in dividends and capital ahead of inflation, by investing principally in global equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Apr 2023 12:19

RNS Number : 0888X
Murray International Trust PLC
21 April 2023
 

MURRAY INTERNATIONAL TRUST PLC (the "Company")

Legal Entity Identifier (LEI): 549300BP77JO5Y8LM553

 

21 April 2023

 

Board Succession Update

 

As indicated in the Annual Report for the year ended 31 December 2022, Mr David Hardie will be retiring from the Board on 31 December 2023 and Ms Virginia Holmes will become Chair with effect from 1 January 2024. Ahead of these changes, the Board of Murray International Trust PLC is pleased to announce the appointment of Mr Gregory Eckersley with effect from 1 May 2023 and Ms Wendy Colquhoun with effect from 1 September 2023 as independent non-executive Directors. 

 

David Hardie, Chairman, commented on the appointment:

 

"I am delighted to announce the appointments of Mr Gregory Eckersley and Ms Wendy Colquhoun to the Board.

 

Greg is an experienced equity investor with a professional executive career in a mix of leadership and asset management roles. Having begun his investment career at Cigna International Investment Limited, he gained international experience at Draycott Partners, Alliance Capital, and Alliance Bernstein, managing, and overseeing teams investing in emerging market and global portfolios before accepting the role of global head of internal equities at the Abu Dhabi Investment Authority (ADIA). After six years with ADIA, he returned to the UK in 2019 to run his own consultancy, Ecko Limited, offering strategic advice to small and early stage businesses. Greg will join the Board on 1 May 2023.

 

Wendy will join the Board on 1 September 2023. She is a qualified solicitor and was, until May 2020, a partner at international law firm CMS Cameron McKenna Nabarro Olswang LLP. She has advised investment trust boards for over 25 years on advisory and transactional matters and has a thorough understanding of investment trusts and the regulatory and other challenges they face. She is a non-executive director of Capital Gearing Trust p.l.c and Schroder UK Mid Cap Fund plc and chair of Henderson Opportunities Trust plc.

 

Disclosures under paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules:

 

Ms Colquhoun is a non executive Director of the following publicly quoted companies:

Capital Gearing Trust p.l.c, Schroder UK Mid Cap Fund plc and Henderson Opportunities Trust plc.

 

Mr Eckersley resigned as a Director of Lekoil Limited (listed on AIM) on 4 January 2020.

 

There are no other disclosures required to be made for Mr Eckersley and Ms Colquhoun, in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Neither Mr Eckersley nor Ms Colquhoun holds any Ordinary shares in the Company.

 

 

abrdn Holdings Limited

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABBGDSUBDDGXB
Date   Source Headline
7th Mar 202412:36 pmRNSNet Asset Value(s)
6th Mar 20245:25 pmRNSMonth End Net Asset Value(s)
6th Mar 20245:14 pmRNSTransaction in Own Shares
6th Mar 202411:46 amRNSNet Asset Value(s)
5th Mar 20245:17 pmRNSTransaction in Own Shares
5th Mar 202412:40 pmRNSNet Asset Value(s)
4th Mar 20245:12 pmRNSTransaction in Own Shares
4th Mar 20242:18 pmRNSGearing disclosure
4th Mar 202412:13 pmRNSNet Asset Value(s)
1st Mar 20245:42 pmRNSTransaction in Own Shares
1st Mar 202410:48 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSAnnual Financial Report
29th Feb 202412:55 pmRNSNet Asset Value(s)
28th Feb 20243:00 pmRNSHolding(s) in Company
28th Feb 202411:33 amRNSNet Asset Value(s)
27th Feb 20245:19 pmRNSTransaction in Own Shares
27th Feb 202412:46 pmRNSNet Asset Value(s)
26th Feb 20245:36 pmRNSGearing Disclosures
26th Feb 202412:42 pmRNSNet Asset Value(s)
23rd Feb 202412:20 pmRNSNet Asset Value(s)
22nd Feb 202412:52 pmRNSNet Asset Value(s)
21st Feb 20245:36 pmRNSTransaction in Own Shares
21st Feb 20244:49 pmRNSHolding(s) in Company
21st Feb 202412:48 pmRNSNet Asset Value(s)
20th Feb 20245:34 pmRNSTransaction in Own Shares
20th Feb 20243:24 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSNet Asset Value(s)
20th Feb 202410:03 amRNSHolding(s) in Company
19th Feb 20245:31 pmRNSTransaction in Own Shares
19th Feb 202412:50 pmRNSGearing disclosure
19th Feb 202411:56 amRNSNet Asset Value(s)
16th Feb 20245:20 pmRNSTransaction in Own Shares
16th Feb 202412:35 pmRNSNet Asset Value(s)
15th Feb 20245:27 pmRNSTransaction in Own Shares
15th Feb 202411:06 amRNSNet Asset Value(s)
14th Feb 20245:27 pmRNSTransaction in Own Shares
14th Feb 202412:36 pmRNSNet Asset Value(s)
14th Feb 202410:41 amRNSPortfolio Disclosures
13th Feb 20245:13 pmRNSTransaction in Own Shares
13th Feb 202412:22 pmRNSNet Asset Value(s)
9th Feb 20245:35 pmRNSTransaction in Own Shares
9th Feb 202412:34 pmRNSNet Asset Value(s)
8th Feb 20245:02 pmRNSTransaction in Own Shares
8th Feb 202411:53 amRNSNet Asset Value(s)
7th Feb 20245:10 pmRNSTransaction in Own Shares
7th Feb 20241:12 pmRNSNet Asset Value(s)
7th Feb 202411:17 amRNSMonth End Net Asset Value(s)
6th Feb 20245:18 pmRNSTransaction in Own Shares
6th Feb 202412:12 pmRNSNet Asset Value(s)
5th Feb 20245:20 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.